Ari Zoldan | TalkMarkets | Page 1

Ari Zoldan

CEO, Quantum Media Group | @CNN @CNBC @FOX covering business and technology | On-Air Talent |
Contributor's Links: AriZoldan.com
Ari Zoldan is the CEO of Quantum Media Group, a global marketing and media agency. As an on-air TV personality, Ari can be seen regularly on FOX, CNN & CNBC covering technology, media and business trends. Ari serves as Chair of the Media & Development ...more
Following: 48 Followers: 2031

Articles

Latest Posts
1 to 15 of 15 Posts
How The Same Treatments May Work For Multiple Neurodegenerative Diseases
Thursday, September 21, 2023 2:15 PM EDT
Extensive research on NDDs has uncovered a different treatment pathway that's enabling some biotechnology firms to target more than one NDD with the same drug candidate.
In this article: COYA, ATHA, ALEC, BIVI
Read
Why The Apple Watch Comes Up Short In Heart Attack Detection… And Other Alternatives
Monday, March 6, 2023 8:34 PM EDT
While there can be some value in having a single-lead ECG always available, patients with known heart conditions need much better technology.
In this article: AAPL Also: ABT, BEAT
Read
How To Take Advantage Of The Great Resignation To Grow Your Public Company
Tuesday, April 26, 2022 2:09 PM EDT
The phenomenon has come to be known as the Great Resignation, or, more informally, the Big Quit. It refers to the approximately 33 million Americans who have resigned since spring of 2021.
Read
Safe-T Group - An Emerging Cybersecurity And Privacy Solutions Provider
Friday, October 1, 2021 11:49 AM EDT
Safe-T Group Ltd. is a global provider of innovative cyber-security and privacy solutions to consumers and enterprises.
In this article: SFET Also: PHG, CHKP, EBAY
Read
Blink Charging: Powering The Electric Ecosystem
Thursday, July 22, 2021 10:46 AM EDT
It is common knowledge that moving forward, electric vehicles (EVs) will dominate the transportation industry.
In this article: BLNK Also: TSLA, SBUX, META, MCD, SONY, CHPT
Read
Protalix: Leveraging Tech In Developing Therapies For Orphan Diseases
Sunday, July 4, 2021 1:34 AM EDT
The company’s risk to reward scenario looks favorable, and we expect significant upside from current levels.
In this article: PLX Also: NVS, SNY, RHHBY, AMGN, CELG
Read
ESG: What Does The Future Of Investing Look Like?
Tuesday, June 22, 2021 11:59 AM EDT
Is ESG a marketing gimmick? Or a fundamentally based investment strategy? And is ESG something that an average investor should take notice of and incorporate into their portfolios for the long term?
Read
NFTs: Are We Creating Value? A Look At 3 Major Players
Sunday, June 20, 2021 1:12 AM EDT
From art and music to GIFs and tweets, the so-called digital assets, or NFTs, are being sold for millions of dollars. Are these digital assets really worth it? How can one gain exposure to these assets without actually buying these assets?
In this article: DLPN, WKEY, PONGF Also: HOFV, TKAT, NET
Read
Inhibikase Therapeutics: Targeted Therapies That Can Improve Quality Of Life
Thursday, June 17, 2021 12:10 PM EDT
If the company gets the approval for IkT-148009, which is the company’s lead small drug candidate, and any progress is seen in other drug candidates, the shareholder value creation will be significantly greater than the projection mentioned above.
In this article: IKT Also: ABV, AZN, BIIB, DNLI
Read
Walmart’s Poor Price Action Amid Strong Results Suggests Lower Prices Lie Ahead
Thursday, August 27, 2020 11:06 AM EDT
Walmart had reported robust same-store comparable sales, which increased by 9.3% versus estimates for 5.4%. However, the company noted comparable sales were normalizing and had fallen to 4% in July.
In this article: WMT
Read
A Bumpy Road To The Uber IPO?
Tuesday, September 26, 2017 6:57 PM EDT
Uber has had a rocky history with regulators from the very start. What will the future look like for Uber and the challenges to an IPO?
Read
Immune Pharma To Unlock Value And Create Two Separate Pure Play Companies; Cytovia, Immune
Tuesday, July 11, 2017 3:13 PM EDT
Immune expects that the focus of Cytovia will be the European market for the drug, which has an addressable market of $175 million, while Pint will focus on the Latin America market with an addressable market of $100 million.
In this article: IMNP Also: MYL, BMY, MRK, SNY, TYO, GSK, ARIA, NVS
Read
Athleisure Remains The Best “Fit” In Fashion Stocks
Friday, April 7, 2017 2:31 PM EDT
Gym clothing being worn causally is by no means a new trend, but it remains a growing one. With a recently estimated market size of $44 billion in the U.S. alone, the obsession over workout apparel seems to be far from waning.
In this article: JWN, M, AEO, GPS, NKE, UA, LULU, ADDYY, JCPNQ, BEBE
Read
Who Are The Next Acquisition Targets In Dermatology?
Wednesday, March 22, 2017 8:25 AM EDT
Specialty pharmaceuticals is a highly dynamic sector with robust stock valuations and an active mergers & acquisition market. One of the most attractive areas for investment is dermatology.
In this article: IMNP, AZN, PFE, SNY, ANAC, RGEN, DERM, FOMX, LBTSF
Read
Here’s How Sensors Are Going To Change Everything
Tuesday, April 19, 2016 11:17 AM EDT
Sensor technology is growing increasingly popular in both the industrial and consumer sectors and across industries.
In this article: FIT, F, GE
Read
1 to 15 of 15 Posts